Watch the recording
About the Event
Tech4Eva is partnering with DayOne, the Healthcare Innovation initiative powered by Basel Area Business & Innovation and invites you to attend this online event on October 18th. Connect with investors, experts and leaders in healthcare on the best corporate partnership strategies and investment opportunities to scale your start-up.
Switzerland's healthtech sector is booming is very well placed to become a center of excellence in Femtech due to its great network of medtech and pharma or medtech corporates present as well as an innovation culture producing great start-ups. The Healthvalley regroups over 1000 organisations including accelerators such as Tech4Eva in Lausanne and DayOne in Basel. We are also lucky to have access to high quality Universities and centers of research promoting innovation at its core.
Hear from 2022 cohort start-up b-rayZ how they recently closed a round of CHF4 million and how they are augmenting mammography with AI as well as learn from pharma corporates such as Bayer G4A, Roche and Novartis Biome how they collaborate with start-ups such as Babyscript and Pollie.
-Learn about corporate and start-up collaboration in Femtech
-Get insights about the ecosystem and trendsin Switzerland from PwC
-Meet the innovative solutions of the Tech4Eva start-ups
Discover the Swiss ecosystem and join us online on October 18.
Cristina is a mother, entrepreneur and a data analyst. After her masters in Physics and the PhD in Biophysics, she started her academic career in the most prestigious European universities. She is author of numerous scientific publications, received prestigious research grants, and is a medical faculty lecturer. In December 2019, she co-founded b-rayZ, a spin-off of the University Hospital of Zürich developing AI solutions for the early detection of breast cancer. The company has reached an exceptional traction with commercial, technical, and clinical success in a short time.
Cécile Tardy-Srinivasan has been working for Basel Area Business & Innovation since 2021.
Previously, she worked at big pharma companies like Novartis, where she held various roles at country, regional and global levels. She brings a background in finance from working with EY. As a healthcare innovation consultant, she focuses on patient centricity and co-creating solutions among stakeholders of the healthcare ecosystem.
Cécile Tardy-Srinivasan studied Design Thinking at the MIT Sloan School of Management and holds a Master’s in Management from the EDHEC Business School, France.
Lan is the Deputy Managing Director of EPFL Innovation Park and an Expert of Innosuisse – the Swiss Innovation Agency. She has 23 years of hands-on professional experience in industry as well as in the ecosystem of innovation & entrepreneurship.
Lan started her career at R&D department of Rolex, in charge of creating new computer aided design and optimisation tools in the product development process. She was later appointed as Head of Operational Planning at Pictet, working closely with a startup to design, develop and implement a management information system for group operation control. As the Managing Director of Geneva Creativity Center, she connected large corporations, SMEs, startups and researchers to initiate innovative joint R&D projects.
Currently at EPFL Innovation Park, she is leading entrepreneurship training and acceleration programs and is helping startups to establish business partnership with large corporations. Lan has a PhD degree from EPFL, an MBA from HEC Lausanne and postdoctoral applied research experience at Stanford University.
Robert Scott is the Global Head of Product & Network Portfolio at the Novartis Biome. The Novartis Biome acts as the integrator and orchestrator across the entire healthcare ecosystem to unite innovative teams together to create impactful partnerships at scale.
Previous to Novartis, Robert led Innovation, Engagement & Experience Strategy for a number of life science clients at Accenture, and led Innovation and Transformation programs at Takeda and Syngenta. Previous to Life Sciences, Robert worked in Technology for a company that was acquired by GoDaddy, the world’s largest internet services company, and in Media for The Economist Group, one of the world’s oldest and most trustworthy media companies.
Sophie joined Bayer's Digital Strategy team in 2016 under the Board of Management for Innovation leading the development and implementation of Bayer AG's digital and transformation strategy.
For a decade, she has held various roles within the healthcare industry through advising, consulting and leading NGOs, multinational corporates, and government institutions in not only developing their digital health growth and investment strategy, but also launching innovation frameworks and programs both in the United States and abroad. She is passionate about public health and scaling sustainable and equitable access for people through digital health.
Currently, she leads the strategic digital health investments through G4A as the Managing Director of G4A Strategic Investments and Partnerships.
Jonathan Sander is a manager at PwC with over 7 years of combined industry and consulting experience in medical devices and pharma. He has worked across the value chain with a particular interest in 3D printing and digital health.
Jonathan is passionate about technology that drives outcomes for patients and healthcare stakeholders. He supports pharma and Medtech companies to define sustainable solutions, engage with their customers and help them with their go-to-market approach.
Jonathan has an engineering PhD from ETH Zürich and an MBA from the University of St.Gallen.
Jane has been passionate about women's health, and more specifically hormonal health, since being diagnosed with PCOS nearly a decade ago.
She previously focused on digital health companies as a management consultant (PwC) and VC (NGP Capital) and decided to start Pollie to fix a problem she has experienced firsthand repeatedly: finding proper hormonal health support
Mylene Jeandupeux is leading the digital medicine and engagement team as a director in the commercial strategy practice in Switzerland. She has over eight years of experience in consulting, where she led major projects in customer-centric digital transformation, commercial strategy and business model definitions.
Mylene has been involved in defining digital health strategies for MedTech and Pharma which includes the design and development of digital health solutions, the ecosystem fit, as well as the launch readiness process. Mylene holds a Master's in Business Management from the University of St.Gallen.
15:00 Welcome Remarks & Intros
Speakers: Douglas Haggstrom of University of Basel, Cécile Tardy of DayOne, and Lan Zuo Gillet of EPFL Innovation Park
15:15 Digital Health Trends in Switzerland
Speakers: Jonathan Sander and Mylène Jeandupeux of PwC
15:30 Tech4Eva Showcase of Selected Growth Stage Start-ups
7 Start-ups: Sabrina Badir of Pregnolia, Sven Mulfinger of Dana Health, Oana Gharbi of Proov, Liza Velarde of Delee, Rob Milnes of Vio Healthtech, Rebecca Sternberg of AquaFit, and Cristina Rossi of b-rayZ
15:40 Panel Discussion: "Corporate Collaboration with Start-ups
Speakers: Sophie Park, Managing Director of Bayer G4A, Juan Pablo Segura, Co-Founder & President of Babyscript, Rob Scott, Global Head of Product & Network of Novartis Biome, Alberto Tomatis, Digital InnovationLAB Director of Roche, and Jane Sagui, Co-Founder of Pollie
Moderator: Douglas Haggstrom of University of Basel
16:10 Tech4Eva Showcase of Selected Growth Stage Start-ups
7 Start-ups: David Stoikovitch of Moona, Tzali Cnaani of Carmel Diagnostics, Eva Galant of Hashiona, Marc Finch of PreTel, Nadia Prisant of IMMA, Ruben Molina of INNITIUS, and Hélène Guillaume Pabis of Wild AI
16:20 Fireside Chat: "The Journey of Fundraising"
Speakers: Cristina Rossi, CEO of b-rayZ
Moderator: Douglas Haggstrom of University of Basel